Lexicon Pharmaceuticals (LXRX) Treasury Shares (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Treasury Shares of $2.8 million for Q1 2026, down 45.19% year-over-year from $5.2 million in Q1 2025, and down 45.19% quarter-over-quarter from $5.2 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Treasury Shares (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Treasury Shares for 17 consecutive years, with $2.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares fell 45.19% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (down 45.19% YoY), while the FY2025 annual figure was $5.2 million, up 12.39% from the prior year.
- Treasury Shares retreated to $2.8 million in Q1 2026 per LXRX's latest filing, from $5.2 million in the prior quarter.
- Across five years, Treasury Shares topped out at $16.5 million in Q1 2025 and bottomed at $867973.0 in Q4 2023.
- Historically, Treasury Shares has averaged $7.8 million across 5 years, with a median of $5.5 million in 2023.
- Annual changes were most pronounced in 2022 — Treasury Shares slumped 72.59% — and 2024, when it soared 59.97%.
- Lexicon Pharmaceuticals' Treasury Shares stood at $2.1 million in 2022, then soared by 39.98% to $2.9 million in 2023, then jumped by 59.97% to $4.6 million in 2024, then gained by 12.39% to $5.2 million in 2025, then plunged by 45.19% to $2.8 million in 2026.
- Business Quant data shows LXRX's Treasury Shares at $2.8 million in Q1 2026, $5.2 million in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | 2.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.51 Mn |
| Jun 30, 2026 | 2.84 Mn |
| Jun 30, 2026 | 15.51 Mn |
| Jun 30, 2026 | 2.84 Mn |
| Mar 31, 2026 | 16.16 Mn |
| Mar 31, 2026 | 16.16 Mn |
| Mar 31, 2026 | 2.84 Mn |
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | 5.19 Mn |
| Dec 31, 2025 | 5.19 Mn |
| Dec 31, 2025 | 2.38 Mn |
| Dec 31, 2025 | 2.38 Mn |
| Sep 30, 2025 | 15.47 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Sep 30, 2025 | 15.47 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | 16.32 Mn |
| Jun 30, 2025 | 16.32 Mn |
| Jun 30, 2025 | 5.19 Mn |